Pharma Focus Asia
KP - Sustainable Packaging Solutions

Romark Constructs New Manufacturing Facility in Manati

Introduction:
Romark constructs a new state-of-the-art facility located in Manati, Puerto Rico. The new manufacturing facility is estimated with an amount of more than US$80 million.

Features:
The manufacturing facility will be designed with an area approximately covering 35,000 square feet. The facility will be dedicated for the production of Alinia (nitazoxanide) tablets, 500 mg and Alinia (nitazoxanide) for Oral Suspension, 100 mg/5mL in the US market.

It will support the development and distribution of NT-300 (nitazoxanide extended-release tablets) an investigational new drug candidate, which is under clinical trials for the prevention and treatment of COVID-19 and other viral respiratory illnesses.

The new facility designed with advanced equipment will manufacture tablets, powders and other oral solid dosage forms. Moreover, this expansion will increase the capacity to develop and deliver medicines.

Once the construction of this new state-of-the-art facility is completed an additional 100 new employees will be positioned.   

Specifications:

NameRomark
Type   Expansion
BudgetUS$80 million

 

Latest Issue
Get instant
access to our latest e-book
Standard BioTools™MFA + MMA 2024Gibco Adherent Kidney Media PanelAsia Healthcare Week 2024Equinix accelerated medical research...CPHI Korea 2024CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?